1344027-40-2 Usage
Uses
Used in Pharmaceutical Industry:
5-Bromo-2-methyl-thiophene-3-carboxylic acid is used as a versatile building block in the synthesis of various pharmaceuticals. Its carboxylic acid functional group allows for easy derivatization and coupling with other molecules, making it a valuable intermediate in the development of new drugs.
Used in Agrochemical Industry:
5-Bromo-2-methyl-thiophene-3-carboxylic acid is also used in the synthesis of agrochemicals, such as pesticides and herbicides. Its unique structure and reactivity make it a useful component in the design and production of effective and targeted agrochemicals.
Used in Dye and Pigment Production:
5-Bromo-2-methyl-thiophene-3-carboxylic acid is a valuable intermediate in the production of dyes and pigments. Its bromine and sulfur atoms contribute to the compound's color and stability, making it suitable for use in the creation of a wide range of dyes and pigments for various applications.
Used in Specialty Chemicals:
5-Bromo-2-methyl-thiophene-3-carboxylic acid is also used in the production of specialty chemicals, such as fragrances, flavorings, and other chemical compounds with unique properties. Its versatility and reactivity make it an important building block in the synthesis of these specialty chemicals.
Check Digit Verification of cas no
The CAS Registry Mumber 1344027-40-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,4,4,0,2 and 7 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1344027-40:
(9*1)+(8*3)+(7*4)+(6*4)+(5*0)+(4*2)+(3*7)+(2*4)+(1*0)=122
122 % 10 = 2
So 1344027-40-2 is a valid CAS Registry Number.
1344027-40-2Relevant academic research and scientific papers
ERK INHIBITORS
-
Page/Page column 19; 20, (2016/07/27)
The present invention provides thieno[2,3-c]pyrrol-4-one compounds that inhibit activity of extracellular-signal-regulated kinase (ERK) and may be useful in the treatment of cancer.
NOVEL THIOPHENE DERIVATIVE AS SGLT2 INHIBITOR AND PHARMACEUTICAL COMPOSITION COMPRISING SAME
-
Page/Page column 17; 29, (2012/03/27)
The present invention relates to a novel compound with thiophene ring having an inhibitory activity against sodium-dependent glucose cotransporter 2 (SGLT2) being present in the intestine and kidney, and a pharmaceutical composition comprising the same as
Novel thiophenyl C-aryl glucoside SGLT2 inhibitors as potential antidiabetic agents
Lee, Suk Ho,Song, Kwang-Seop,Kim, Jong Yup,Kang, Misuk,Lee, Jun Sung,Cho, Seung-Hwan,Park, Hyun-Ju,Kim, Jeongmin,Lee, Jinhwa
experimental part, p. 5813 - 5832 (2011/11/04)
Novel thiophene C-aryl glucoside SGLT2 inhibitors were designed and synthesized. Two different types of thiophene derivatives were readily prepared. Among the compounds tested, ethylphenyl at the distal ring 71p showed the best in vitro inhibitory activit
